SAN DIEGO, Feb. 24, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the ...

On Dec. 9-10, skywatchers across parts of Canada, the U.S. and Europe will witness a very rare occultation of the bright star ...

Tonight, look up in the sky. Look east and you will see the moon and Regulus unite, giving all of the residents of Earth (who are keen on stargazing) a unique concert. This concert begins in the ...

At 6 A.M. EDT, Mercury will pass 1.2° north of Regulus, observable in the east before sunrise from locations with clear eastern horizons. Mercury, with a magnitude of –1.3, will reach an altitude of ...

Maybe the third time's the charm? Regulus Therapeutics is once again shuffling its pipeline and sliding a new kidney disease candidate into the high-priority queue, hoping for better fortunes after a ...

TOLEDO, Ohio — If you’re an early riser (or willing to become one), the morning of Saturday, Sept. 20, promises one of the best naked-eye sky events of the year: a slim crescent moon, the brilliant ...

Sanofi is letting go of a genetic kidney disease therapy under development with Regulus Therapeutics after getting a peak at an interim analysis. Development will be shut down for the anti-microRNA 21 ...

A rare cosmic sight will grace the night sky this week when the huge the asteroid Erigone passes in front of the bright star Regulus, as seen from Earth, on the night of March 19 and 20. The event, ...

Regulus (RGLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...

On March 20, 2014, the bright asteroid Regulus will "wink" out when it is eclipsed (or "occulted") by the huge asteroid 163 Erigone. It is an extremely rare celestial event only visible from a slim ...